Hepatoprotective effect of nanoniosome loaded Myristica fragrans phenolic compounds in mice-induced hepatotoxicity

In this study, nanoniosome-loaded Myristica fragrans' (MF) phenolic compounds (NLMP) were synthesized and characterized for their physical properties, and hepatoprotective effects on mice with liver toxicity induced by L-asparaginase (LA) injection. According to the results, NLMP has a spherical shape with a 263 nm diameter, a zeta potential of -26.55 mV and a polydispersity index (PDI) of 0.192. The weight and feed intake of mice induced with hepatotoxicity were significantly (p <= 0.05) increased after they were treated with NLMP (2.5 mg/kg body weight of mice). In addition, the blood levels of triglyceride (TG), cholesterol (Chol), liver enzymes (aspartate aminotransferase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP)) and total bilirubin were significantly (p <= 0.05) decreased. A significant increase (p <= 0.05) in the blood levels of the antioxidant defence system (glutathione peroxidase (GPX), superoxide dismutase (SOD) and catalase (CAT)) were also reported after NLMP treatment. NLMP was also led to a significant decrease (p <= 0.05) in inflammatory-related gene expression of inducible nitric oxide synthase (iNOS) and Interferon-gamma (IFN-gamma) in the liver, as well as a meaningful (p <= 0.05) increase in the expression of SOD as an antioxidant status biomarker. Consequently, the NLMP is recommended as a potential dietary supplement to alleviate the symptoms of LA-induced hepatotoxicity.

Automated summary

In this study, nanoniosome-loaded Myristica fragrans' phenolic compounds (NLMP) were synthesized and characterized. The NLMP showed hepatoprotective effects on mice with liver toxicity induced by L-asparaginase injection. NLMP treatment increased the weight and feed intake of mice, decreased the blood levels of triglyceride, cholesterol, liver enzymes, and total bilirubin, and increased the levels of the antioxidant defence system. NLMP also downregulated the expression of inflammatory-related genes and upregulated the expression of SOD in the liver.